Skip to main content
OpenTrials
Completed

NCT Number: NCT02905825

Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics

Clinical Study to Confirm Safety and Accuracy in Detection of H. pylori with 13C-Urea Breath Test using the BreathID® Hp and BreathID® Hp Lab Systems in the Pediatric Population

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Assaf Harofe Medical Center, Tzrifin, Israel

Loading trial locations.

About this study

Pediatric subjects with indication for H.pylori testing, will be tested with both stool antigen as a reference standard and a urea breath test using the BreathID® Hp and BreathID® Hp Lab Systems. The BreathID® Hp system continuously measures breath via a nasal cannula and the BreathID® Hp Lab System measures breath collection bags before and after ingestion of a solution with enriched carbon 13 urea and citric acid. The stool sample will be provided within a week of the breath tests and will be analyzed by a central laboratory. Safety and overall efficacy will be assessed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be older than 3 and younger than 18 years of age
  • Present with a clinical indication compatible with H. pylori based on the judgement of the treating physician (such as abdominal pain, nausea, diarrhea, reflux, peptic ulcer, dyspepsia, etc., or following treatment for H.pylori)
  • Subject/Legal guardian (and subject whenever relevant) is willing to sign the Informed Consent/Assent Form
  • Naïve to H. pylori treatment in the past 6 weeks

Exclusion criteria

  • Participation in other interventional trials
  • PPI or H2 blockers within two (2) weeks prior to breath test/stool antigen test
  • Pregnant or breastfeeding female
  • Allergy to test substrates
  • Antibiotics (not related to H. pylori eradication) and/or Bismuth preparations within four (4) weeks prior to breath test
  • Exposure to any type of anesthesia, analgesics or sedation 24 hours prior to the breath test.
  • Exposure to any 13C-enriched substance 24 hours prior to the breath test.
  • Children 12 years and older - to be excluded after a written notification from the sponsor is received at the site that the limit of 1/3 of the sample size was achieved for this group
  • Subjects outside US - to be excluded after a written notification from the sponsor is received at the site that the limit of 1/3 of the sample size was achieved for this group

Treatment and study plan

BreathID® Hp System

Device

Breath will be analyzed for change in carbon 13 content in breath after ingestion of carbon 13 enriched urea

BreathID® Hp Lab System

Drug

Breath will be analyzed for change in carbon 13 content in breath after ingestion of carbon 13 enriched urea

Stool Test

Diagnostic Test

Each subject was asked to perform a stool test in parallel to the breath test.

Other names: Stool Antigen Test

Primary outcomes

  1. Number of Participants With Reported Adverse Events

    Time frame: 24 hours

    Number of participants with reported adverse events after performing urea breath test

Secondary outcomes

  1. Percentage of Agreement

    Time frame: 1 week

    Percentage of agreement between stool test reference standard and continuous urea breath test in assessing presence or absence of Helicobacter pylori infection

  2. Percentage of Agreement

    Time frame: 1 week

    Percentage of agreement between stool test reference standard and breath bags from urea breath test in assessing presence or absence of Helicobacter pylori infection

Sponsors and collaborators

Lead sponsor

Meridian Bioscience, Inc.

Industry

Registry information

Official study title

Clinical Confirmation Study to Confirm Safety and Presence of H. Pylori With 13C-Urea Breath Test Using the BreathID® Hp and BreathID® Hp Lab Systems in the Pediatric Population

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Sep 19, 2016
Registry last updated
Dec 20, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.